Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished Dec 1, 2025 9:00 AM ・ Updated Jun 13, 2026 11:48 PM ・ 2 min read ・ Source: PR Times
BaoLing-FuJin Biotech Co., Ltd. (Stock Code: 1760) has released its financial results for the fourth quarter of 2025. The company reported basic earnings per share (EPS) of NT$2.22 for the quarter. Quarterly operating revenue reached NT$2.063 billion, with a net profit after tax of NT$190 million. BaoLing-FuJin continues its development in the biotechnology and medical sector.
Company Code: 1760 Company Name: BaoLing-FuJin Biotech Co., Ltd. Industry: Biotechnology and Medical Year/Quarter: 2025 Q4 Basic Earnings Per Share: NT$2.22 Operating Revenue: NT$2.063 billion Net Profit After Tax: NT$190 million
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.